Cirqle Biomedical
cirqle.bio
Actively hiring
Prescription Drugs
Women’s Health & Maternity
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Pre-Seed
Aug 2019 · 7 yr ago
Team
1-10
employees, estimated range
The money's age
Long since its last round
85 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Pre-Seed | Aug 2019 | — | — | businesswire.com |
Investors in similar startupsfunds that back the companies most like this one
backs Hera Biotech
backs OCON Therapeutics
Similar startupsby what they do, their industry and backers
Birth control, UTIs, herpes, prescription skincare, weight care & more—all online with licensed providers. Insurance and Medicaid accepted…
Women-built and data-encrypted, Stardust is the only period, hormone, ovulation & pregnancy app that blends science and astronomy to track…
Oula delivers comprehensive maternity care from midwives & OBGYNs, including prenatal care, hospital birth, postpartum care, & gynecology.
Diagnosing Endometriosis and Cervical Cancer—In Tissue. On Time. For Her.
Your trusted source for information and fast, easy-to-use products for women's health conditions.
Tuune is a personalized women's healthcare company that is dedicated to improving the management of hormonal conditions for women.
News
Organon And Cirqle Biomedical Enter Research Collaboration And License Agreement For Investigational Non-Hormonal, On-De...
Read more
Report
Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate Financial Post
Read more
Report
Organon & Co.: Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate
Collaboration continues to expand portfolio in women's health to help address unmet needs Organon (NYSE: OGN), a global women's healthcare company, and Cirqle Biomedical today announced they have
Read more
Report
Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate
"This collaboration is an important opportunity to advance our preclinical research exploring this asset' s first-in-class potential," said Frederik Petursson Madsen, Cirqle Biomedical, CEO." We are excited to join Organon to leverage Organon' s deep expe
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Frederiksberg
Denmark
HQ
1-10 est. staff
Financials
Latest round
Pre-Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Pre-Seed | 2019 | — | Details |